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ABSTRACT
Radiation exposure is both a major obstacle in space exploration and an
occupational hazard for various careers causing DNA damage and ROS. In order to
reduce the effects of radiation, the primary and most explored approach has been focused
around mitigation in terms of exposure duration, exposure intensity, and shielding usage.
In some situations none of these reduction strategies were viable and so the use of
antioxidants is being explored as an alternate strategy for therapeutic purposes. One such
antioxidant is curcumin, otherwise known as diferuloylmethane, is a component of
turmeric with both antioxidant properties and anti-inflammatory properties. Another
antioxidant that could be used to scavenge free radicals, n-Acetylcysteine (NAC), is both
a pharmaceutical drug and a dietary supplement. Finally n-2-mercaptopropionyl glycine
(N-MPG) is an antioxidant used in the treatment of kidney stones. These radioprotectants
are used primarily to mitigate ROS induced by radiation but have short half-lives in
physiological conditions and poor bioavailability.
Liposomes can be used to entrap materials such as NAC, N-MPG, and curcumin.
Liposomes can entrap hydrophobic molecules such as curcumin within the bilayer itself
or hydrophilic materials such as NAC and N-MPG within the aqueous interior of the
liposome. Liposomes can be used to deliver their contents to cells via membrane fusion.
Small unilamellar vesicles (SUVs) were fabricated by sonication for this purpose and
SUVs were evaluated according to size, toxicity, and antioxidant capacity.
Dynamic Light Scattering (DLS) measurements showed that the limiting
hydrodynamic radius of the SUVs had been reached for all conditions. Limiting
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hydrodynamic radius was approximately 130nm for Soy-PC/DOTAP loading conditions
and approximately 140nm for DOPC/POPA loading conditions. SEM imaging confirmed
both spherical and unilamellar morphology of SUVs. Theoretical encapsulation
efficiency (EE) was near 100% for curcumin loading conditions. For both NAC and NMPG, EEs were calculated to be 0.88% and 0.90% for Soy-PC/DOTAP and
DOPC/POPA loading conditions respectively. MTT assays showed no significant
cytotoxicity at the concentrations of both antioxidant and lipid that were used for future
evaluations. Amplex Red assay results showed that the fabrication process did not
significantly reduce the antioxidant capacity of Soy-PC/DOTAP loaded with NAC or
curcumin. Based on these results, it was recommended that Soy-PC/DOTAP loaded with
curcumin be investigate for further use.
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NOMENCLATURE
ROS=Reactive Oxygen Species
LET=Linear Energy Transfer
DMTHC=Dimethyltetrahydrocurcumin
NAC=N-Acetylcysteine
N-MPG=N-2-Mercaptopropionyl Glycine
Soy-PC=Soy-Phosphatidylcholine
DOTAP=1,2-dioleoyl-3-trimethylammonium-propane
DOPC=1,2-dioleoyl-sn-glycero-3-phosphocholine
POPA=1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate
SUV=Large Unilamaellar Vesicle
SUV=Small Unilamellar Vesicle
HBSS=Hanks Balanced Salt Solution
DLS=Dynamic Light Scattering
SEM=Scanning Electron Microscope
HDF=Human Dermal Fibroblast
MTT=3-(4,5-Dimethylthiazol-2yl)-2,5-Diphenyltetrazolium Bromide
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HRP=Horseradish Peroxidase
B/M=Buffer Diluted Media
SD0=Soy-PC/DOTAP SUVs with 0% antioxidant (unloaded)
SDC1,SDC2,SDC10=Soy-PC/DOTAP SUVs loaded with 1%, 2%, 10% curcumin
SDN1,SDN2,SDN10=Soy-PC/DOTAP SUVs loaded with 1%, 2%, 10% NAC
SDM1,SDM2,SDM10=Soy-PC/DOTAP SUVs loaded with 1%, 2%, 10% N-MPG
DP0= DOPC/POPA SUVs with 0% antioxidant (unloaded)
DPC1,DPC2,DPC10=DOPC/POPA SUVs loaded with 1%, 2%, 10% curcumin
DPN1,DPN2,DPN10=DOPC/POPA SUVs loaded with 1%, 2%, 10% NAC
DPM1,DPM2,DPM10=DOPC/POPA SUVs loaded with 1%, 2%, 10% N-MPG
C10=Free (unloaded) Curcumin at an equivalent concentration to 10% loaded curcumin
N10= Free (unloaded) NAC at an equivalent concentration to 10% loaded NAC
M10= Free (unloaded) N-MPG at an equivalent concentration to 10% loaded N-MPG
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I.

INTRODUCTION
1.1 Background
Radiation exposure is both a major obstacle in space exploration and an occupational

hazard for various careers. Radiation exposure can manifest itself as both immediate cell
damage or as highly reactive oxygen free radicals[1]. The creation of energized reactive
oxygen species (ROS) is the most well understood mechanism of radiation damage
typically associated with low linear energy transfer (LET) radiation. These ROS will lead
to the generation of highly reactive compounds that are shown to react with DNA bases
and organelles[2]. This indirect mechanism can occur over time and has the additional
potential to affect cells that have not been irradiated in what is known as the “Bystander
Effect”[3]. High LET radiation can also cause the creation of ROS but due to its higher
energy density, has the additional potential to directly cause DNA lesions (Figure 1) and
damage in cellular organelles resulting in more immediate and more varied cell damage
[4]. If radiation damage is unable to be repaired, it typically expresses itself as acute cell
death or chronic cell dysregulations such as cancer.
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Figure 1: DNA Damage through Ionized Radiation and Antioxidant Benefit[5]
In order to reduce the effects of radiation, the primary and most explored
approach has been focused around mitigation in terms of exposure duration, exposure
intensity, and shielding usage. Since radiation is only directional in very controlled
environments, exposure avoidance is frequently not a viable option. In addition,
mitigating exposure time can still allow for significant radiation damage based on the
intensity of the radiation and is not applicable in space and upper atmosphere operations.
The most viable option to mitigate radiation in terms of received radiation reduction has
been the use of shielding which comes with the requirement of high density materials
which are frequently very expensive and can be a major detriment to any situation in
which mobility is required. Specifically in the field of space exploration, the weight of
shielding has a prohibitive effect on launch costs. An alternate approach to radiation
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reduction is the use of supplements to mitigate the damage caused by the radiation
received by the astronauts[6]. These supplements can be broadly named radioprotectants
and are typically antioxidants[7]. Antioxidants function by eliminating ROS from the
body and can prevent much of the long term damage and low LET radiation damage
through ROS scavenging.
1.2 Antioxidants
One such antioxidant is curcumin (Figure 2), otherwise known as
diferuloylmethane, is a component of turmeric with both antioxidant properties and antiinflammatory properties. Curcumin is hydrophobic and soluble in acetone. The
hydrophobic properties of curcumin’s diketone group provide a ready location for
hydrolysis and for ROS scavenging. In addition to the diketone group, the two phenolic
hydroxyl groups have been shown to function as antioxidants as well (Figure 3). In
addition to its ability to ROS scavenge, curcumin has been shown to up-regulate the
expression of p53 which is identified as mediating DNA repair gene expression[8].
Curcumin also has the benefit of low toxicity; no toxic effects of oral doses of up to 8g
daily after which point it was reported that consumption volume became the primary
obstacle rather than toxicity. The very low oral toxicity is due in part to the low
bioavailability of curcumin with peak serum levels after 1 hour being on the nanomolar
scale[9]. The low blood serum levels of curcumin can be attributed to its rapid
degradation and high liver clearance rate[10]. In physiological conditions, 90% of
curcumin degradation has occurred in 30 minutes which is a severe limitation in its
therapeutic use[11]. Because the primary mechanism for curcumin degradation is
hydrolysis of the diketone moiety, the degradation of curcumin also removes a portion of
15

its antioxidant capabilities although some breakdown components retain antioxidant
function (Figure 4).

Figure 2: Curcumin Molecular Structure [12]

Figure 3: Reaction Pathway of Curcumin with Oxidizing Radicals[13]
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Figure 4: Curcumin Degradation Products[14]
Another antioxidant that could be used to scavenge free radicals, n-Acetylcysteine
(NAC) (Figure 5) is both a pharmaceutical drug and a dietary supplement.
Pharmaceutically used to treat acetaminophen overdoses, NAC has received additional
attention as a general health and bodybuilding supplement[15]. ROS scavenging for
cysteines occurs through the formation of a disulfide bridge (Figure 6). Additionally
NAC both up regulates and provides a precursor molecule (cysteine) to glutathione in the
body which is an antioxidant and a regulatory signal for biological responses to ROS[16,
17]. However, disulfide bonds can form spontaneously when thiol groups are exposed to
most oxidizing agents and therefore can reduce the efficacy of NAC as an antioxidant. A
further challenge in the use of NAC is that it has a half-life of 1-2 hours in physiological
conditions[18] which makes it difficult to maintain therapeutic concentrations of the
antioxidants.
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Figure 5: NAC Molecular Structure

Figure 6: Disulfide Bride Formation [19]
N-2-mercaptopropionyl glycine(N-MPG)(Figure 7), is also known as tiopronin
and marketed under the trade name of Thiola® (Mission Pharmacal, San Antonio, Tx) in
order to prevent the formation of kidney stones in patients who are resistant to diet
modifications[20]. Like NAC, N-MPG has a thiol group with which antioxidant function
stems from. N-MPG therefore, also functions as an antioxidant through the use of a
disulfide bridge to reduce the effects of free radicals. Also like NAC, N-MPG suffers
from a 1-2 hour half-life under physiological conditions which limits the therapeutic
concentration that can be maintained[21].
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Figure 7: N-MPG Molecular Structure
1.3 Lipid Vesicles
Liposomes can be used to entrap materials such as NAC, N-MPG, and Curcumin.
Liposomes can entrap hydrophobic molecules such as curcumin within the bilayer itself
or hydrophilic materials such as NAC and N-MPG within the aqueous interior of the
liposome[22]. Conventional liposome delivery of materials occurs through endocytosis
and is limited by the rate at which this occurs[23]. Fusogenic liposomes fuse directly with
the cell membrane to deliver materials rather than through endocytosis and can be used
allow for faster, more consistent delivery of materials. Once entrapped, the lipid vesicles
can be used to both protect its contents from outside degradation sources and
subsequently as a delivery vehicle to deliver the entire contents of the vesicle to a cell by
fusion. Lipid vesicles also have the ability to entrap hydrophobic molecules such as
curcumin within the bilayer itself (Figure 8) which allows for the protection of curcumin
from diketone hydrolysis, the primary mechanism of curcumin degradation, in addition to
allowing full delivery of curcumin into target cells upon vesicle fusion[24].
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Figure 8: Curcumin Containing Lipid Vesicle[25]
Two different liposome compositions were studied. The first composition was
Soy-Phosphotidylcholine (Soy-PC) and 1,2-dioleoyl-3-trimethylammonium-propane
(DOTAP) (50:1 mol/mol respectively) and the second composition was 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate
(POPA) (50:1 mol/mol respectively)[26]. Soy-PC (Figure 9) and DOPC (Figure 10) are
act as stable vesicle formers that comprise the majority of the liposomes and provide
stability to the vesicles formed. Soy-PC is actually a heterogeneous mixture of
phosphatidylcholines of which the most common species is shown in figure 9. DOTAP
(Figure 11) is a cationic lipid and POPA (Figure 12) is an anionic phospholipid both of
which are unstable vesicle formers used to impart fusogenic properties to vesicles.
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Figure 9: Soy-PC Primary Species Molecular Structure[26]

Figure 10: DOPC Molecular Structure[26]

Figure 11: DOTAP Molecular Structure[27]

Figure 12: POPA Molecular Structure[27]

21

While lipid vesicles spontaneously form upon rehydration, their formation will
occur in varying sizes and with a varied number of bilayers. In order to create unilamellar
vesicles of consistent sizes, high stress mixing methods such as sonication,
emulsification, and homogenization must be used[28]. For small batch development (<10
mL), probe sonication is the most applicable and will be used to create unilamellar
vesicles for testing. The sonication process used here creates small unilamellar vesicles
(SUVs) that were at their limiting hydrodynamic radius.
1.4 Hypothesis
Antioxidant loaded SUVs can be fabricated via probe sonication and maintain
antioxidant function without an increase in cytotoxicity while increasing cellular uptake
of the antioxidants and decrease ROS levels in human dermal fibroblasts.
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II.

METHODS
2.1 Small Unilamellar Vesicle (SUV) Fabrication
SUV synthesis by sonication involves two phases, a drying phase to remove the

chloroform solvent and a rehydration phase to hydrate the lipid material. For the drying
phase, 5 mg (125 µl at 40 mg/ml) of Soy-PC (Avanti, Birmingham, AL) and 0.090 mg
(36.6 µl at 2.5 mg/ml) of DOTAP (Avanti) were added to a test tube. A second lipid
composition of 5 mg (200 µl at 25 mg/ml) DOPC (Avanti) and 0.089 mg (35.4 µl at 2.5
mg/ml) of POPA (Avanti) was also examined for comparative purposes in this study.
Chloroform was the solvent for all lipids.
For testing conditions that required the addition of curcumin (Sabinsa), the
curcumin was dissolved in acetone and added into the lipid solution. The amount of
curcumin at a 1:10, 1:50 and 1:100 molar ratio of (curcumin: lipid) and labelled as 10%,
2%, and 1% curcumin loading respectively. 10% curcumin can also be considered as
130.4µM. Once the components were added into the test tube, a stream of nitrogen gas
was then used to evaporate off the solvents. Once dried, the remaining lipid residue was
light protected and placed under vacuum storage (Thermo, Air Cadet) for a minimum of
12 hours to ensure removal of trace amounts of solvent.
For the rehydration phase, the lipid residue was suspended in 5 mL of Hank’s
Balanced Salt Solution (HBSS) (Sigma, St. Louis, MO) and 10 mM Trizma base (Sigma)
at pH 7.4. NAC (Sigma) and N-MPG (Sigma) concentrations were calculated relative to
their solvent (water) and therefore 10% NAC and 10% N-MPG were 0.1 mg/mL. For
both NAC and N-MPG, 10% can also be considered 612µM. For a given 5 mL sample of
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10% NAC/N-MPG, 0.5 mg of NAC/N-MPG was added to the lipid suspension. Two
5mm glass beads (Sigma) were then added to assist in removal of the lipid residue from
the test tube surface. The test tubes were parafilmed and vortexed for 30 seconds then
placed in a 370C water bath for 1 hour. During the hour in the water bath, the samples
were vortexed for 30 seconds every 15 minutes to ensure complete hydration of the
sample. After the water bath, the samples were then transferred to 15 mL centrifuge tubes
and probe sonicated (Branson, Sonifier 450) with a booster horn and micro-tip probe at
50% duty cycle and an output control of 7 (micro-tip limit). Sonication was continued
until the limiting hydrodynamic radius was reached. The limiting particle radius was
considered to be the size where there was no longer a significant reduction in SUV
diameter with additional sonication time. To assist in keeping sonication parameters
consistent over multiple batches, the samples were kept in a cold water bath (160C-180C)
and the probe was placed both centrally and as deep as possible without causing
cavitation of the suspended sample. The samples were then centrifuged at 3100 rpm
(Beckman, TJ-6) for 5 minutes to remove titanium particles that erode from the sonicator
tip during use. Samples were then transferred to another centrifuge tube without
disturbing the pellet and analyzed by DLS (Wyatt, DynaPro) for average diameter and
polydispersity. The software package Dynamics V6 was used in conjunction with the
DLS. Samples were then, capped, protected from light, and stored at 4 0C until use within
1 day of production.
2.2 Dynamic Light Scattering (DLS) analysis
Each SUV sample was analyzed by DLS (Wyatt, DynaPro) in order to determine
the hydrodynamic radius of the SUVs. Hydrodynamic radius is a measure of particle size
24

calculated from particle diffusion rates based on the Stokes-Einstein equation[29]. DLS
size calculations were performed at room temperature and based on a preprogrammed
model for globular proteins. A minimum of 50 readings per sample was taken for all
samples which were analyzed immediately after liposome production with a minimum
intensity of 20,000 cnts/mL. The metrics of mean diameter, diameter standard deviation,
and sample polydispersity were noted for each sample.
2.3 SEM Imaging
In order to examine SUV morphology, 5µL of sample was placed on a silicon
wafer, covered, and allowed to air dry at room temperature for a minimum of 12 hours.
The silicon wafers were then placed on copper stubs and were imaged by SEM (Zeiss
Evo, 3.22 kV, InLens detector). Images were able to be obtained without sputter coating
for Soy-PC/DOTAP liposomes and DOPC/POPA samples required sputter coating for
1minute using gold/palladium with parameters of 150 V, 0.1 mA, and under a 0.1 torr
vacuum. For both SUV compositions, unloaded samples and samples loaded at 10%
concentrations were analyzed for morphological changes since any morphological
changes that occurred at 1% and 2% loading conditions were expected to be similar to
10% loading but much harder to visualize.
2.4 Theoretical Loading Efficiency of SUVs
Because of the difficulty separating SUVs from solution, theoretical loading
efficiency was determined to estimate the amount of antioxidant contained within the
SUVs. For curcumin, because it was not water soluble and was trapped within the lipid
bilayer prior to rehydration, loading efficiency was considered to be at or very near 100%
25

for both SUV compositions. For NAC and N-MPG, loading was expected to follow the
model of hydrophilic drug entrapment for SUVs. Hydrophilic antioxidant encapsulation
efficiency was calculated according to the equation in Figure 13. The encapsulation
efficiency equation takes the metrics of particle size, standard deviation, bilayer
thickness, molecular polar surface area, lipid concentration, and sample volume to
estimate the percentage of antioxidant encapsulated. The encapsulation efficiency
equation can be broken down into inner volume (Vi), vesicle count, and total sample
(outer) volume (V). Inner volume was determined as a function of radius (Ri) and bilayer
thickness (d). Vesicle count was determined by the lipid concentration (C) and the
number of lipid molecules per vesicle (NA) was based on bilayer surface area and the
exposed area of a single lipid molecule (a). This calculation was then repeated with
probability weights (Pi) over a log normal distribution vesicle sizes. Based on the
encapsulation efficiency equation, the hydrophilic encapsulation efficiency for SoyPC/DOTAP and DOPC/POPA SUVs were 0.88% and 0.90% respectively.

Figure 13: Hydropilic Drug Encapsulation of Liposomes[22]
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2.5 Human Dermal Fibroblast (HDF) cell culture
All cell based analysis was performed with human dermal fibroblasts (HDF).
HDF passage number was not allowed above 20. HDFs were cultured in RPMI 1640
(Thermo, Waltham, MA) with 10% fetal bovine serum (Thermo) and 1% penicillinstreptomycin (Thermo). HDFs cultured in 96 well plates were given 100 µL of media and
those cultured in 48 well plates were given 250 µL of media. Cell seeding densities were
10,000 cells per well for 96 well plates and 30,000 cells per well for 48 well plates and all
experiments were performed at full confluence.
2.6 Cellular Uptake of Curcumin from SUVs
SUV delivery of antioxidants was estimated based on cellular curcumin uptake in
HDFs. Curcumin is naturally fluorescent in the green spectrum (Ex at 420 nm and Em at
470 nm) and therefore can be visualized with a FITC filter on a fluorescent microscope
(Nikon, Eclipse Ti). Curcumin uptake was examined visually to determine pre-incubation
times for future cell based assays
2.7 MTT Assay for Cytotoxicity
Cytotoxicity assays for all conditions were performed in 96 well plates on
confluent HDFs. Promega’s CellTiter 96 Non-Radioactive Cell Proliferation Assay kit
(Promega, Madison, WI) was used to assess cellular viabilty after 24 hours of SUV
treatments. All treatment conditions and controls were removed, washed with phosphate
buffered saline (Thermo), and given fresh media after 24 hours of treatment time
immediately before performing the MTT assay. The formazan forming tetrazolium dye
was incubated at 37 0C protected from light for 2 hours and the stop solution was
27

incubated protected from light at room temperature for on an orbital rocker (Barnstead,
model# 4631) for 1 hour. All observed bubbles were then removed from each sample and
the absorbance was read on a plate spectrophotometer at 562 nm (BioTek, ELx800).
2.8 Lipid Hydroperoxidation
As a precursor assay to the measurement of antioxidant capacity, lipid
hydroperoxidation measurements were required to obtain the amount of peroxides
produced by the SUV degradation. These measurements were taken using the
PeroxiDetect Kit (Sigma). A stock of 90% methanol was created by 108 mL of methanol
with 12 mL water. A stock solution of Organic Peroxide Color Reagent was created by
reconstituting the entire contents of the kit stock bottle in 120 mL of 90% methanol. A
Working Color Reagent was then created by adding 100 volumes of the reconstituted
Organic Color Reagent to 1 volume of Ferrous Ammonium Sulfate Reagent. Then 100
µL of sample was placed into a cuvette to which 1 mL of the Working Color Reagent was
added. The samples were then protected from light and incubated at room temperature for
30 minutes. Samples absorbance was then measured by a spectrophotometer (Thermo) at
560 nm. A standard curve was created using tert-butyl hydroperoxide as a positive
control without lipids.
2.9 Antioxidant Capacity
The antioxidant capacity of the samples given to HDFs was determined using an
Amplex Red hydrogen peroxide assay kit from Invitrogen. The Amplex Red assay was
performed in a 48 well plate on confluent HDFs and requires the use of RPMI 1640
without phenol red with 25 mM HEPES (Calbiochem, San Diego, CA) and 1%
28

penicillin-streptomycin (Sigma). Prior to performing the assay, stock solutions of reaction
buffer, horseradish peroxidase (HRP), and Amplex Red (Cayman) were created. The
reaction buffer was 25 mL of 50 mM sodium phosphate at pH 7.4. The HRP stock
solution (Invitrogen) was dissolved in reaction buffer at 10 U/mL and divided into 120
µL aliquots for future use. The Amplex Red stock solution was dissolved into DMSO
(Sigma) at 390 µL/mg and then divided into 60 µL aliquots. SUV blank controls, free
antioxidant controls, and antioxidant loaded SUVs were added with fresh media and
given a 20 minute pre-incubation time at 37 0C. After the pre-incubation time, 125 µL of
100 µM hydrogen peroxide (Sigma) was added to the relevant samples and allowed to
incubate at 37 0C for 10 minutes. A stock of working Amplex Red was then made by
mixing 50 µL of an Amplex Red aliquot, 100 µL of an HRP aliquot, and 2.42 mL of
reaction buffer. Next, 125 µL of working Amplex Red was then added to all samples and
allowed incubate at 37 0C for 1 hour. After the addition of both the hydrogen peroxide
and the Amplex Red, the final concentrations of both the Amplex Red and hydrogen
peroxide dilute to 25 µM. The absorbance was read on a plate spectrophotometer
(BioTek, ELx800) at 562 nm.
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III.

RESULTS
3.1 SUV Size Analysis and Production
Because SUVs naturally form over a range of sizes, forcing SUVs towards the

limiting hydrodynamic radius was necessary to produce a batch of SUVs with consistent
vesicle size. Initial samples for both Soy-PC/DOTAP and DOPC/POPA SUVs (Figures
14 and 15) showed that sonication does force SUV size towards the limiting
hydrodynamic radius. In addition, the sonication times at which the limiting
hydrodynamic radius was being approached for both Soy PC-DOTAP and DOPC/POPA
SUVs were 3 to 4 minutes. A change of SUV diameter of less than 10% was used as a
metric to determine that the SUV size was approaching the limiting hydrodynamic radius
after which further sonication would not cause significant size reduction. Therefore,
additional analysis began with multiple samples at 3 minutes of sonication time.
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Figure 14: Unloaded Soy-PC/DOTAP SUV Size vs Sonication Time. Less than 10% size
change occurred between 3 and 4 minutes of sonication time.

Figure 15. Unloaded Soy-PC/DOTAP SUV Size vs Sonication Time. Less than 10% size
change occurred between 3 and 4 minutes of sonication time.
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SUV size analysis was used to determine if the limiting hydrodynamic radius had
been reached for all conditions at the sonication times indicated by the estimates provided
by Figures 14 and 15. If the mean SUV size was not statistically different between 2
sonication times, the limiting hydrodynamic radius had been achieved. The results of
tables 1 and 2 showed that the limiting hydrodynamic radius had been reached between 3
and 4 minutes for all conditions except for sdn10, dpc10, dpn2, and dpn10. A high
curcumin concentration, such as dpc10, will interfere with lipid formation until even
dispersion throughout the lipid bilayers is achieved through further sonication. The
results of table 3 show that the limiting hydrodynamic radius had been reached for sdn10,
dpc10, and dpn2 in between 4 minutes and 5 minutes of sonication time. Table 3 also
showed that the limiting hydrodynamic radius had been reached for dpn10 in between 5
minutes and 6 minutes of sonication time. Based on these results, the production times of
each SUV condition for further studies were placed halfway in between the times in
which the limiting hydrodynamic radius had been reached and the sizes of which are
shown in Table 4.
sd0
3 minutes
122.1 ± 1.6
4 minutes
115.1 ± 4.0
significant diff. no

sdc1
126.2 ± 3.5
113.9 ± 9.9
no

sdc2
120.1 ± 4.6
111.5 ± 6.7
no

sdc10
124.5 ± 2.7
115.7 ± 4.3
no

sdm1
126.7 ± 3.8
117.8 ± 9.1
no

sdm2
3 minutes
126.8 ± 5.7
4 minutes
117.4 ± 8.5
significant diff. no

sdm10
129.0 ± 3.2
113.5 ± 6.7
no

sdn1
122.6 ± 3.2
117.8 ± 1.7
no

sdn2
127.2 ± 6.4
116.8 ± 1.3
no

sdn10
123.4 ± 4.0
113.0 ± 2.9
yes
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Table 1: Size Analysis of Mean Diameter vs Sonication Times for Soy-PC/DOTAP
SUVs. Table shows that only sdn10 had a significant size difference between 3 and 4
minutes as shown by t-tests, p=0.05, n=3
dp0
3minutes
143.8 ± 10.0
4minutes
130.4 ± 9.1
significant dif. no

dpc1
150.8 ± 2.0
137.5 ± 4.3
no

dpc2
149.0 ± 5.6
132.5 ± 2.9
no

dpc10
*
129.0 ± 2.8
n/a

dpm1
146.2 ± 6.7
131.0 ± 3.8
no

dpm2
3minutes
145.3 ± 4.0
4minutes
133.8 ± 1.0
significant dif. no

dpm10
145.8 ± 3.0
130.6 ± 5.0
no

dpn1
144.0 ± 3.5
130.7 ± 4.0
no

dpn2
140.8 ± 2.7
127.6 ± 1.9
yes

dpn10
142.8 ± 1.1
129.6 ± 1.8
yes

Table 2: Size Analysis of Mean Diameter vs Sonication Times for DOPC/POPA SUVs.
Table shows that only dpn2 and dpn10 had a significant size difference between 3 and 4
minutes as shown by t-tests, p=0.05, n=3
*Lipid precipitate observed at dpc10 3 minutes therefore sample was not viable due to
unknown lipid concentrations of supernatant
sdn10
4minutes
113.0 ± 2.9
5minutes
108.1 ± 4.5
significant dif. no

dpc10
129.0 ± 2.8
119.6 ± 2.0
no

dpn2
127.6 ± 1.9
124.8 ± 1.8
no

dpn10
129.6 ± 1.8 5minutes
121.0 ± 1.6 6minutes
yes
significant dif.

dpn10
121.0 ± 1.6
117.8 ± 1.1
no

Table 3: Size Analysis of Mean Diameter vs Sonication Times for Extended Sonication
Times. Table shows that only dpn10 had a significant size difference between 4 and 5
minutes as shown by t-tests, p=0.05, n=3
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sd0
sdc1
sdc2
sdc10
sdn1
sdn2
sdn10
sdm1
sdm2
sdm10
123.3±8.3 125.0±8.8 125.5±7.0 118.5±6.6 125.0±7.6 125.3±6.7 121.5±6.1 123.6±5.5 127.2±7.7 125.5±8.5
dp0
dpc1
dpc2
dpc10
dpn1
dpn2
dpn10
dpm1
dpm2
dpm10
134.1±7.9 140.2±0.6 138.6±5.0 131.2±5.0 140.0±0.8 124.2±4.8 119.0±3.3 141.4±0.0 139.3±0.4 140.7±4.9

Table 4: SUV Sizes at Production Sonication Times. Table shows the average SUV size
(nm) ± the standard deviation. All conditions have n ≥ 3 other than dpn and dpm loading
conditions (n=2).
3.2 SUV Characterization by SEM
SEM microscopy of SUV samples showed that all imaged Soy-PC/DOTAP SUV
samples had a consistently unilamellar and spherical morphology. DOPC/POPA SUVs
were much more difficult to image most likely due to the lack of charge provided by the
cationic lipid DOTAP and only one out of the 4 conditions attempted were able to be
imaged. DOPC/POPA SUV morphology appears to be unilamellar but less spherical than
the Soy-PC/DOTAP SUVs. For the Soy-PC/DOTAP SUVs, the images shown were
collected without the use of sputter coating. For DOPC/POPA, SUVs needed to be
sputter coated to obtain images. DLS size measurements were considered to be a better
representation of SUV size because DLS measurements were taken while SUVs were still
hydrated and the effects of dehydrating the SUVs for SEM imaging were unknown.
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Panel A: Soy-PC/DOTAP Unloaded SUVs

Panel B: Soy-PC/DOTAP SUVs Loaded with 10% Curcumin
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Panel C: Soy-PC/DOTAP SUVs Loaded with 10% Curcumin

Panel D: Soy-PC/DOTAP SUVs Loaded with 10% N-MPG
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Panel E: DOPC/POPA SUVs Loaded with N-MPG
Figure 16 A-E: SEM Images of SUVs. All SUVs appear to be unilamellar and round.
3.3 SUV Cytotoxicity
Because the SUVs are rehydrated and sonicated in HBSS and Trizma Base,
adding the SUVs to media for cell studies dilutes the media and subsequent nutrients.
Therefore before the cytotoxicity of the SUVs could be studied, the cytotoxicity of the
media dilutions needed to be established. The results of Figure 17 show that media that is
50% HBSS and Trizma base or greater caused significant cytotoxicity. Therefore the
media that was 25% HBSS and Tizma base would be the maximum concentration of
SUVs used in cell studies.
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Cytotoxicity of Media Dilutions
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Figure 17: Cytotoxicity of Media Dilutions (Note: Buffer is HBSS and 10mM Trizma
base). Significant cytotoxicity differences are noted with * at 50% and 100% buffer in
media as tested by ANOVA, p<0.05, n=5, and with Tukey’s post test.
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Figure 18: Cytotoxicity of Unloaded Soy-PC/DOTAP SUVs Normalized to Respective
Media Dilutions. No significant cytotoxic effects were seen as tested by ANOVA,
p<0.05, n=5, and with Tukey’s post test.
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Unloaded SUV cytotoxicity was needed to establish the maximum concentration
of SUVs that could be used to treat HDFs. The results in Figure 18 and Figure 19 indicate
that there was no significant toxicity in either of the SUV compositions for all
concentrations when compared to their respective controls of equivalent media
conditions. Because the SUV batches were produced at a concentration of 1 mg/mL in
buffer, the fraction of media that was buffer can be correlated directly to the lipid
concentration (e.g. 0.25 mg/mL SUV had a respective control of media that was 25%
buffer). Neither SUV composition was cytotoxic to the HDFs and thus both SUV
compositions were used at 0.25 mg/mL for future studies.
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Fig 19: Cytotoxicity of Unloaded DOPC/POPA SUVs Normalized to Respective Media
Dilutions. No significant cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5,
and with Tukey’s post test
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Loaded SUV cytotoxicity was investigated to determine if the concentrations of
antioxidants being used were cytotoxic to HDFs. Because of the lipid dilutions due to the
cytotoxicity results of unloaded SUVs, loaded SUV molarities are reduced to 32.6µM for
curcumin and 153µM for NAC/N-MPG. The results shown in Figures 20, 21, and 22
show that there were no significant cytotoxic effects of the antioxidants on HDFs. This
data indicates that all tested concentrations of antioxidants can continue to be evaluated
without significant toxic effects to the HDFs. Previous unpublished data by our group
indicated that neither free NAC nor free N-MPG would have significant cytotoxic effects
at the concentrations that were tested in the MTT assay. Our group has previously shown
that curcumin would be cytotoxic above 10 uM which was below the concentration of
curcumin used (32.6 uM). The discrepancy between toxicity levels shown in Figure 20
and the previous lab data could be attributed to the curcumin being obtained from Sabinsa
while curcumin for previous data was obtained from Sigma. Another possible reason for
the curcumin toxicity discrepancy is that while not significant, the reduced HDF
metabolism caused by the 25% media dilution could reduce the amount of toxic
byproducts of curcumin metabolism. A third possibility is that a portion of the curcumin
was not released if the SUVs had not had a chance to fuse with the cells although given
that the study took place over the course of 24 hours, it is expected that the fraction of
unfused SUVs remains very small. While not significant, DOPC/POPA SUVs showed a
lower toxicity than the Soy-PC/DOTAP SUVs and free antioxidants.
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Cytotoxicity of Soy-PC/DOTAP
SUVs Loaded With Curcumin
1.2

Normalized
Cytotoxicity

1.0
0.8
0.6
0.4
0.2

in

Fr

ee

10
%

C
ur

cu
m

di
ng

g

lo
a

di
n

g
Lo
a

di
n
2%

Lo
a

1%

U

nl
oa
de
d

SU
Vs

0.0

Conditions

Figure 20: Cytotoxicity of Soy-PC/DOTAP SUVs Loaded with Curcumin. No significant
cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5, and with Tukey’s post
test.
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Figure 21: Cytotoxicity of DOPC/POPA SUVs Loaded with Curcumin. No significant
cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5, and with Tukey’s post
test.
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Cytotoxicity of Soy-PC/DOTAP
SUVs Loaded With NAC
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Figure 22: Cytotoxicity of Soy-PC/DOTAP SUVs Loaded with NAC. No significant
cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5, and with Tukey’s post
test.
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Figure 23: Cytotoxicity of DOPC/POPA SUVs Loaded with NAC. No significant
cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5, and with Tukey’s post
test.
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Cytotoxicity of Soy-PC/DOTAP
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1.2

Normalized
Cytotoxicity

1.0
0.8
0.6
0.4
0.2

1%

U

nl
oa
de
d

SU
Vs

Lo
ad
in
g
2%
Lo
ad
in
g
10
%
lo
ad
in
g
Fr
ee
N
-M
PG

0.0

Conditions

Figure 24: Cytotoxicity of Soy-PC/DOTAP SUVs Loaded with N-MPG. No significant
cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5, and with Tukey’s post
test.
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Figure 25: Cytotoxicity of DOPC/POPA SUVs Loaded with N-MPG. No significant
cytotoxic effects were seen as tested by ANOVA, p<0.05, n=5, and with Tukey’s post
test.
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3.4 SUV Antioxidant Capacity
3.4.1 SUV Hydroperoxidation
Determining SUV hydroperoxidation was necessary in order to determine if lipid
degradation was producing peroxides that would take away from antioxidant capacity.
The results of Figure 23 indicate that there is less than 0.2 nmoles of lipid hydroperoxides
in both SUV compositions. This indicates that oxidative degradation of the lipids happens
slowly enough that there is negligible peroxidation of the SUVs before they are subjected
to hydrogen peroxide based antioxidant capacity evaluation.

Fig 26: 48 Hour Lipid Hydroperoxidation
3.4.2 SUV Pre-Incubation Time for Antioxidant Capacity
Based on the visually estimated level of fluorescence shown by curcumin in the
HDFs, it was determined that SUV delivery occurs after 1 minute of incubation time and
that there was no noticeable reduction of curcumin in the cells through 40 minutes of
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incubation. The Soy-PC/DOTAP images were taken using Metamorph software and the
DOPC/POPA images were taken using NIS Elements software. Because curcumin photobleaches quickly and image capturing was taken by hand instead of automated,
quantification of the fluorescence would not be accurate and so quantification of the
fluorescence seen in the images would not be accurate. Previous data from our group
showed that peak curcumin levels occurred at 15 minutes and showed no decrease until
30 minute incubation. Based on fluorescent estimates of the curcumin levels and previous
SUV data by our group, a pre-incubation time of 20 minutes was used for antioxidant
capacity assays.

Figure 27: Pre-Incubation Images for Soy-PC/DOTAP SUVs at 10x magnification.
Images show that curcumin is present in the cells at all timepoints
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Figure 28: Pre-incubation images for DOPC/POPA SUVs at 10x magnification . Images
show that curcumin is in the cells at all timepoints.
3.4.3 Amplex Red Hydrogen Peroxide Assay
Antioxidant capacity is used to demonstrate the efficacy of the antioxidants
against ROS as simulated by hydrogen peroxide. Statistical analysis of curcumin loaded
SUVs (Figures 29 and 30) showed that all loading conditions except for DOPC/POPA
SUVs loaded with 1% curcumin created a significant peroxide reduction from unloaded
SUVs. Statistical analysis also showed that the beyond 1% loading Soy-PC/DOTAP
curcumin loading conditions exhibited a significant peroxide reduction when compared to
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DOPC/POPA. Finally statistics showed that free curcumin had a significant peroxide
reduction compared to DOPC/POPA SUVs loaded with 10% curcumin but not compared
to Soy-PC/DOTAP SUVs loaded with 10% curcumin. After the addition of the hydrogen
peroxide and Amplex Red dye, 10% curcumin treatments had 16.3µM curcumin and
25µM hydrogen peroxide. From this, the normalized peroxide reduction was used to
calculate that 1.5, 1.6, and 1.9 moles of free curcumin, Soy-PC/DOTAP loaded with 10%
curcumin, and DOPC/POPA loaded with 10% curcumin respectively were used to
eliminate 1 mole hydrogen peroxide. This implies that there is no loss in antioxidant
function due to fabrication for Soy-PC/DOTAP SUVs.
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Figure 29: Peroxide Reduction of Soy-PC/DOTAP SUVs Loaded with Curcumin.
*=Significant difference from all other groups except for free curcumin as tested by
ANOVA, n=4, p<0.05, with Tukey’s post test.
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Figure 30: Peroxide Reduction of DOPC/POPA SUVs Loaded with Curcumin.
*=Significant difference from all other groups as tested by ANOVA, n=4, p<0.05, with
Tukey’s post test.
Statistical analysis of NAC loaded SUVs (Figures 31 and 32) showed that there
was no significant peroxidation decrease from unloaded conditions for DOPC/POPA
until 10% NAC loading was reached while Soy-PC/DOTAP loading conditions reached
significance at 2% NAC loading concentrations. Statistical analysis of Figures 31 and 32
also showed that free NAC showed a significant decrease in peroxidation from
DOPC/POPA SUVs loaded with 10% NAC but not from Soy-PC/DOTAP SUVs loaded
with 10% NAC. After the addition of the hydrogen peroxide and Amplex Red dye, 10%
NAC treatments had 76.5µM NAC and 25µM hydrogen peroxide. From this, the
normalized peroxide reduction was used to calculate that 5.5, 5.9, and 6.4 moles of free
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NAC, Soy-PC/DOTAP SUVs loaded with 10% NAC, and DOPC/POPA SUVs loaded
with 10% NAC respectively were used to eliminate 1 mole hydrogen peroxide. This
implies that there was significant loss in antioxidant function for NAC loaded
DOPC/POPA SUVs during production but not for the Soy-PC/DOTAP counterparts. The
moles of NAC required to neutralize 1 mole of hydrogen peroxide is much higher than
the moles of curcumin required for the same effect which could potentially be attributed
to spontaneous formation of disulfide bonds between NAC molecules.
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Figure 31: Peroxide Reduction of Soy-PC/DOTAP SUVs Loaded with NAC.
*=Significant difference from all other groups except for free NAC as tested by ANOVA,
n=4, p<0.05, with Tukey’s post test.
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Figure 32: Peroxide Reduction of DOPC/POPA SUVs Loaded with NAC. *=Significant
difference from all other groups as tested by ANOVA, n=4, p<0.05, with Tukey’s post
test.
Statistical analysis of N-MPG loaded SUVs (Figures 33 and 34) showed that there
was no significant peroxidation decrease from unloaded conditions for DOPC/POPA
until 10% N-MPG loading was reached while Soy-PC/DOTAP loading conditions
reached significance at 2% N-MPG loading concentrations. Statistical analysis of Figures
33 and 34 also showed that there was a statistical difference in peroxide reduction
between free N-MPG, DOPC/POPA SUVs loaded with 10% N-MPG, and SoyPC/DOTAP SUVs loaded with 10% N-MPG. Soy-PC/DOTAP SUVs loaded with 10%
N-MPG therefore, had significantly less peroxide reduction from free N-MPG but
significantly more reduction that DOPC/POPA SUVs loaded with 10% N-MPG. This
implies that there is a significant decrease in antioxidant function for N-MPG loaded
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SUVs for both compositions. After the addition of the hydrogen peroxide and Amplex
Red dye, 10% N-MPG treatments had 76.5µM N-MPG and 25µM hydrogen peroxide.
From this, the normalized peroxide reduction was used to calculate that 4.7, 5.6, and 7.9
moles of free N-MPG, Soy-PC/DOTAP SUVs loaded with 10% N-MPG, and
DOPC/POPA SUVs loaded with 10% N-MPG respectively were used to eliminate 1 mole
hydrogen peroxide. The moles of N-MPG required to neutralize 1 mole of hydrogen
peroxide is much higher than the moles of curcumin required for the same effect which
could be attributed to the formation of disulfide bonds between N-MPG molecules.
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Figure 33: Peroxide Reduction of Soy-PC/DOTAP SUVs Loaded with N-MPG.
*=Significant difference from all other groups as tested by ANOVA, n=4, p<0.05, with
Tukey’s post test.
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Figure 34: Peroxide Reduction of DOPC/POPA SUVs Loaded with N-MPG.
*=Significant difference from all other groups as tested by ANOVA, n=4, p<0.05, with
Tukey’s post test.
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IV.

CONCLUSIONS, DISCUSSION, AND FUTURE WORK
The low theoretical encapsulation efficiency could become a major obstacle in the

use of SUVs for the delivery of hydrophilic materials. This low encapsulation efficiency
could be offset by increasing the concentration of the lipids in solution before sonication
although that would change the time for the limiting hydrodynamic radius to be reached.
This could also be offset by increasing the concentration of the material to be entrapped
with cytotoxicity being the limiting factor. Both of these parameter changes should be
explored and needed based on required therapeutic concentrations of hydrophilic
material. A size exclusion column to separate unencapsulated material followed by the
use of HPLC could be used to obtain a loading efficiency for hydrophilic materials in a
SUV.
While not statistically significant, it should be noted that DOPC/POPA SUVs had
less cytotoxicity compared to Soy-PC/DOTAP SUVs which may become important if
Soy-PC/DOTAP SUVs demonstrate significant toxicity with other cell lines. In order to
reduce overall toxicity for future cell studies, SUV production at higher lipid
concentrations should be investigated in order to mitigate the negative effects of diluting
the media when adding SUV treatments.
DOPC/POPA SUVs for all 10% loading conditions consistently showed
significantly lower antioxidant function compared to respective loading conditions of
Soy-PC/DOTAP implies that the antioxidant function is better preserved in SoyPC/DOTAP SUVs. To supplement data from the Amplex Red assay, a delivery profile
would be the next ideal step. Degradation based release profile techniques do not apply to
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fusogenic SUVs since their mechanism of delivery is fusion rather than degradation
making the tracking of released antioxidants require the presence of cells. Nile Red is a
lipophilic fluorescent dye that may be able to track the SUV fusion and should be
investigated. An initial potential obstacle to fluorescent tracking is that cells with excess
lipid in their membranes will bleb off small portions of the membrane which may limit
the extent to which delivery can be tracked[20].
In summary the research indicated that antioxidant loaded SUVs can be
consistently produced through sonication for both lipid compositions and all antioxidant
loading conditions using DLS measurements. All SUV treatments produced were shown
to not have significant cytotoxic effects on HDFs. Of those treatments, Soy-PC/DOTAP
SUVs loaded with curcumin and loaded with NAC showed no significant loss in
antioxidant function after the fabrication process. For future evaluation in cell
environments exposed to radiation, it is recommended that both the Soy-PC/DOTAP
SUVs loaded with curcumin be explored due to the high encapsulation efficiencies and
the maintained antioxidant capacity when compared to the free antioxidants.
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BRIAN GETTLER
631 Bellamy Circle Apt# 307,
Louisville, KY 40208

Phone:859.312.8118

Email:bcgett01@gmail.com

Bioengineering graduate searching for full time employment with 2+ years of laboratory experience in
biological wet laboratories. Experience in cell culture methods for yeast and human dermal
fibroblasts. Additional experience in electrospun cellular scaffolds and lipid based nanoparticles.
EXPERIENCE

University of Louisville & Energy Delivery Solutions
Research Engineer

August 2013‐Present

Masters of Engineering thesis to evaluate the efficacy of antioxidants used in a radio‐protective role.



Optimized and manufactured lipid vesicle delivery system for antioxidants
Tested efficacy of delivery system and antioxidants in vitro with fibroblasts

Cardiovascular Innovation Institute, Lousville, KY
Research Engineer
July 2013

January 2013‐

Worked independently to manufacture and evaluate cellular scaffolds for potential use in a clinical
pilot trial




Manufactured bio-absorbable cell scaffolds for fistula plugs via electrospinning
Performed in vitro evaluations on scaffolds for cell seeding and infiltration
Helped prepare 1st human clinical trial

Allylix, Lexington, KY
Research Engineer/Research Associate
August 2012

May 2012‐

Worked as a technician with a primary project of assay troubleshooting and secondary tasks of
recombinant yeast mutant screenings. Additional tasks of laboratory cleaning and maintenance.




Troubleshot an assay for gas chromatography based micro-culture screening
Performed yeast/E. Coli transformations (plasmid and recombinant)
Performed micro-culture mutant screening and shake flask mutant screening
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Alltech, Lexington, KY
Laboratory Technician
December 2011

August 2011‐

Worked independently to manufacture and evaluate a bioremediation product with long term goal
of EPA submission.





Manufactured bioremediation product for testing
Data analysis tests performed on product for EPA submission purposes
Data was focused on product growth rates and target material degradation rates
Displayed results in an open presentation
EDUCATION

Bachelors of Science, Bioengineering, University of Louisville, Louisville, KY, 3.13 GPA, July 2013
Masters of Engineering, Bioengineering, University of Louisville, Louisville, KY, 3.51 GPA,
Expected December 2014

TECHNICAL SKILLS

Lab Skills: Cell culture (flask and microscale), sterile technique, fluorescent staining & imaging, H&E
staining, most probable number test, pH, agar plating, selection marker use (i.e. uracil, leucine),
DNA/protein gels & extractions, PCR, optical density measurements
Lab Equipment Used: probe sonicator, SEM, electrospinner, steam autoclave, pH meter, centrifuge,
fluid bed dryer, Rotovap distillation setup, gas chromatograph, 96 well plates, various pipets.
Some experience in: Minitab, Labview, Matlab
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